Measuring muscle strength in clinical trials

The Lancet Neurology

Volumn 9, Issue 12, 2010, Pages 1146-

  Merlini, Luciano ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; PREDNISONE;

CLINICAL TRIAL; DUCHENNE MUSCULAR DYSTROPHY; DYNAMOMETRY; ELBOW FLEXION; HUMAN; LETTER; MEASUREMENT; MEDICAL RESEARCH COUNCIL SCORE; MUSCLE STRENGTH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCORING SYSTEM;

EID: 78349287291     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70285-4     Document Type: Letter

References (3)

1. Kirschner J, Schessl J, Schara U, et al. Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial. Lancet Neurol 2010, 9:1053-1059.
2. Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ Clinical trial in Duchenne dystrophy-I: the design of the protocol. Muscle Nerve 1981, 4:186-197.
3. Cook JD, Glass DS Strength evaluation in neuromuscular disease. Neurol Clin 1987, 5:101-123.